
Progyny (PGNY) Stock Forecast & Price Target
Progyny (PGNY) Analyst Ratings
Bulls say
Progyny is well-positioned in a growing market, with a unique and diversified business model that sets them apart from competitors. Their strong track record of success, expanding client base, and partnerships with health plans make them a promising investment. Additionally, their increased price target and positive outlook for the future further supports a positive sentiment towards this stock.
Bears say
Progyny is facing significant competition from both traditional insurance carriers and emerging start-ups in the fertility benefits management space. This, coupled with potential losses of customers and slower-than-expected expansions into adjacent services, may lead to lower utilization and unfavorablesocioeconomic and political developments, hindering the company's growth and profitability. The company's recent shift from broad-based equity grants to a more normalized run-rate may also lead to increased stock-based compensation expenses.
This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.
Progyny (PGNY) Analyst Forecast & Price Prediction
Start investing in Progyny (PGNY)
Order type
Buy in
Order amount
Est. shares
0 shares